Skip to main content
TipRanks
Go Ultimate75% OFF

Sunho Biologics,Inc. (2898) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Sunho Biologics,Inc. has a market cap or net worth of HKD 970.43M. The enterprise value is HKD 370.01M.

Market Cap
HKD 970.43M
Enterprise Value
HKD 370.01M

Share Statistics

Sunho Biologics,Inc. has 156,666,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
156,666,800
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Sunho Biologics,Inc.’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -18.32%.

Return on Equity (ROE)
-0.16
Return on Assets (ROA)
-0.14
Return on Invested Capital (ROIC)
-18.32%
Return on Capital Employed (ROCE)
-0.20
Revenue Per Employee
292.308
Profits Per Employee
-615.12K
Employee Count
130
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Sunho Biologics,Inc. is -8.77. Sunho Biologics,Inc.’s PEG ratio is -0.17.

PE Ratio
-8.77
PS Ratio
22428.09
PB Ratio
1.37
Price to FCF
-5.38
Price to Operating Cash Flow
-6.44
PEG Ratio
-0.17

Income Statement

In the last 12 months, Sunho Biologics,Inc. had revenue of 38.00K and earned -79.97M in profits. Earnings per share was -0.62.

Revenue
38.00K
Gross Profit
38.00K
Operating Income
-101.36M
Pretax Income
-79.97M
Net Income
-79.97M
EBITDA
-91.92M
Earnings Per Share (EPS)
-0.62

Cash Flow

In the last 12 months, operating cash flow was -22.75M and capital expenditures -41.55M, giving a free cash flow of -64.30M billion.

Operating Cash Flow
-22.75M
Free Cash Flow
-64.30M
Free Cash Flow per Share
-1.23

Dividends & Yields

Sunho Biologics,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-18.59%
Earnings Yield
-11.41%

Stock Price Statistics

Beta
0.00
52-Week Price Change
-13.53%
50-Day Moving Average
6.39
200-Day Moving Average
6.39
Relative Strength Index (RSI)
47.00
Average Volume (3m)
―

Important Dates

Sunho Biologics,Inc. upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 28, 2026
Next Earnings Date
Apr 05, 2027
Ex-Dividend Date
―

Financial Position

Sunho Biologics,Inc. as a current ratio of 11.17, with Debt / Equity ratio of 8.05%

Current Ratio
11.17
Quick Ratio
11.15
Debt to Market Cap
0.08
Net Debt to EBITDA
0.40
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Sunho Biologics,Inc. has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Sunho Biologics,Inc. EV to EBITDA ratio is -8.85, with an EV/FCF ratio of -5.14.

EV to Sales
21415.01
EV to EBITDA
-8.85
EV to Free Cash Flow
-5.14
EV to Operating Cash Flow
-7.46

Balance Sheet

Sunho Biologics,Inc. has HKD 441.40M in cash and marketable securities with HKD 68.24M in debt, giving a net cash position of HKD 373.16M billion.

Cash & Marketable Securities
HKD 441.40M
Total Debt
HKD 68.24M
Net Cash
HKD 373.16M
Net Cash Per Share
HKD 2.38
Tangible Book Value Per Share
HKD 3.12

Margins

Gross margin is 100.00%, with operating margin of -266723.68%, and net profit margin of -210434.21%.

Gross Margin
100.00%
Operating Margin
-266723.68%
Pretax Margin
-210434.21%
Net Profit Margin
-210434.21%
EBITDA Margin
-241902.63%
EBIT Margin
-266723.68%

Scores

Smart Score
―
AI Score
41